Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial - Jürgen Rech; Koray Ta?ç?lar; Melanie Hagen; Arnd Kleyer; Bernhard Manger; Verena Schoenau; Axel J. Hueber; Stefan Kleinert; Xenofon Baraliakos; J. Braun; Uta Kiltz; Martin Fleck; et al. (LANCET, 2024)